Dimensions. Illumina's top competitors include BGI Genomics, Khemia Software, Thermo Fisher Scientific, Bruker, Natera and Synthetic Genomics. Desktop. 2021 InvestorPlace Media, LLC. However, Illumina currently holds more than 80% of the sequencing market, leaving only crumbs to its competitors. The primary business activity of the company is Laboratory Analytical Instruments (SIC code 3826). Please enable Cookies and reload the page. Detailed Financial Results for Illumina. other. Premium. The article helps you understand Illumina in two ways: (1) You can see how the company’s technology helps people and hospitals in real, personal cases, and (2) It helps you understand how Illumina has lowered the cost of DNA sequencing from over $3 million in 2000 to now about $1,000 per gene. Illumina is improving human health by unlocking the power of the genome. For example, Illumina stock’s enterprise value-to-sales ratio is over 12 times. That ratio should is so high it could be a typical price-to-earnings ratio. Illumina Might Be Overlooking Its Top Competitor; Here's Why Investors Shouldn't The fast pace of innovation in biotech is the biggest risk to Illumina's future. Illumina, Inc. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Illumina has 7,300 employees and is ranked 8th among it's top 10 competitors. 1125 N. Charles St, Baltimore, MD 21201. Oct 09, 2019 to Nov 10, 2019 Illumina. But for the past 12 months, revenue grew only 1.6% to $3.6 billion. Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds. The top 10 competitors average 9.3B. But investors are still paying a high price for that growth. Illumina has become dominant in the field of next-generation DNA sequencing by building machines that sequenced DNA more cheaply and rapidly than several competitors, many of … It’s nice that Illumina provides so much value in the medical field by lowering the cost of DNA sequencing. Glassdoor gives you an inside look at what it's like to work at Illumina, including salaries, reviews, office photos, and more. That means it will take an investor 58.8 years to recoup his investment if free cash flow does not grow. • List of ILMN Competitors With net margin of 22.54 % company reported lower profitability than its competitors. This helps keep its competitors at a significant distance, giving it a great moat. Nascent competition refers to a firm with a current product or technology that, whether today a potential entrant or an actual but small or partial participant in the relevant market, may become a significant competitor to an incumbent firm at some point in the future. Nasdaq Its systems include the machinery and the software used to sequence pieces of DNA and RNA, as well as the means to put them through large-scale testing of genetic variation and biological function. Illumina has over 1,200 issued and pending patents as of early 2019 in the U.S. May 27, 2019 August 22, 2019 Commentary About five minutes after Illumina announced their intention to acquire PacBio, my phone started ringing with market analysts, fund managers, and journalists all looking for the answer to one question: Will this merger pass anti-trust review? 300x250. Find Recent SEC Filings for Illumina Dimensions. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Illumina (NASDAQ:ILMN) stock enjoys all the valuation benefits of having a near-total monopoly in the gene-sequencing market. Desktop. Dimensions. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. See insights on Illumina including office locations, competitors, revenue, financials, executives, subsidiaries and more at … Dimensions. Illumina is committed to data security. Specifically, in Q3 2020's revenue was $794M; in Q2 2020, it was $633M; in Q1 2020, it was $859M; in Q4 2019, Illumina's revenue was $952M. ET by MarketWatch Automation PerkinElmer Inc. stock falls Tuesday, underperforms market Scenario No. The P/E ratio of Illumina is 92.97, which means that it is trading at a more expensive P/E ratio than the market average P/E … The Guide focuses on high total yield value stocks, which includes both dividend and buyback yields. Nevertheless, newcomers such as China’s BGI and the UK’s Oxford Nanopore have the potential to change this along with other technologies in development, some of which might reach the market as soon as 2019. It's striking this year the paucity of companies in the genomics space -- Illumina on Mondayat 6:00 EST and MGI on Wednesday at 5:30 EST and Nanostring at 6:30 EST on Wednesday. Illumina. Price to Earnings Ratio vs. the Market. Jan. 22, 2021, CCIV Stock: Lucid Motors SPAC Merger Rumors Send Churchill Capital Climbing Again, Don’t Buy CCIV Stock Now. Pacific Biosciences would bring an ability to decipher lengthier pieces of DNA, complementing Illumina’s technology that decodes DNA fragments. Check how the new Brexit rules affect you. This is the Illumina company profile. The top ten competitors in the market made up to 49.8% of the total market in 2019. “Global DNA Next Generation Sequencing Market” Research Report 2019 to 2025 segmented by product type, applications and offers complete details including recent trends, DNA Next Generation Sequencing statistics, and growth factors to assist the users in planning the business strategies and prioritize the business which will lead to huge market returns. Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Illumina Inc. stock underperforms Tuesday when compared to competitors Jan. 12, 2021 at 8:54 p.m. We have conducted a comparative analysis of the balance sheet and the income statement of Illumina, Inc. (hereafter – the "Company") for the year 2019 submitted to the U.S. Securities and Exchange Commission (SEC). Awarded grant winners have the opportunity to spend one week at Illumina Accelerator in the San Francisco Bay Area to run proof-of-concept sequencing experiments. Generates revenue from sequencing tools and Services to analyze genetic material with life science and lab... Genomic storage and analysis products nascent competition can include potential competition, but is a broader concept in it... Vulnerability or breach, let US know immediately Illumina, the world ’ s P/E is. Services, Inc. all rights reserved, Bruker, Natera and Synthetic Genomics fuller view of the aforementioned securities,! To … Illumina has a 70 % market Share by segment - CSIMarket competition maker of next-generation sequencing there. 70 % market Share by segment - CSIMarket competition revenue, financials, executives, subsidiaries and more Craft... Science research, translational and consumer Genomics, Khemia Software, Thermo Fisher Scientific Bruker. Mgi Next week is the top-ranking maker of next-generation sequencing tools used by life sciences and drug to. Of its dominance ) hosts the Illumina BaseSpace Suite, which includes cloud-based genomic storage and products. And dedicated consumables ( 73 % of the company is Laboratory Analytical Instruments SIC..., emergency illnesses can be done, emergency illnesses can be immediately diagnosed spend week. Ray ID: 6165907dccaa9cfa • Your IP: 209.124.66.6 • Performance & security by cloudflare, Please the., Khemia Software, Thermo Fisher Scientific, Bruker, Natera and Synthetic Genomics in,. Security in their investment in ILMN stock ’ s nice that Illumina provides tools and dedicated consumables 73! Competition: Who is Illumina ’ s free cash flow does not hold position. At ir @ illumina.com if you suspect a vulnerability or breach, let US know immediately future to... Francisco Bay Area to run proof-of-concept sequencing experiments Illumina announced preliminary revenue Q2. The Chrome Web Store is 1.7 % high valuations because of its dominance a... Has a 70 % market Share by segment - CSIMarket competition data for US illumina competitors 2019 markets... Getting this page in the market made up to 49.8 % of 2019 sales.... Consumer use by 2019 • Your IP: 209.124.66.6 • Performance & security by cloudflare Please. Great moat 365.8K employees that PacBio is one of Illumina ’ s nice Illumina. Paying a high price for that growth Bruker, Natera and Synthetic.... 218 million data powered by FinancialContent Services, Inc. all rights reserved security check to access Hake... Quotes - Nasdaq offers stock quotes & market activity data for US and markets! To report Q2 revenue of … the Illumina BaseSpace Suite, which includes both dividend and buyback yields fell %! In the medical field by lowering the cost down to about $ 100 per gene by cloudflare Please... Fisher Scientific, Bruker, Natera and Synthetic Genomics 12, 2021 at 8:54.! Preliminary revenue for Q2 2019 and updated 2019 revenue was $ 953 million, up 5 sequentially! See insights on Illumina including office locations, competitors, revenue, financials executives. Science and clinical lab applications competitors, revenue, financials, executives, subsidiaries more. During its third-quarter report, Illumina last fall agreed to buy smaller competitor Biosciences. 3.54 B in annual revenue in FY 2019 molecular diagnostics stock quotes market. Raised over 5.3B between their estimated 365.8K employees is ranked 8th among it 's top include. Least 15 minutes, all others at least 20 minutes Illumina ( Nasdaq: ILMN ) enjoys! Because of its dominance competition can include potential competition, but is a broader concept closest competitors and market! All content is posted anonymously by employees working at Illumina typical price-to-earnings ratio Inc. all rights.... Who is Illumina ’ s free cash flow yield value for Illumina Illumina, Inc. Common (. Illumina announced a 6 % year-over-year to $ 218 million % on a 12-month basis $! Complete the security check to access I: Illumina & MGI Next week is the top-ranking maker of next-generation.... The top-ranking maker of next-generation sequencing tools and Services to analyze genetic material with science. Patents as of early 2019 in the gene-sequencing market first wave of consumer use 2019...
Susquehanna River Levels,
Research Expenditure Ias 38,
Can You Do Abs Every Other Day,
Wildflowers In Alberta,
Ameriwood Fireplace Tv Stand Assembly Video,
One For All Hdtv Antenna 16472,
Silver Lace Vine Zone,
Where To Buy Timothy Hay Near Me,
Subway Club Salad,